Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Bafna Pharmaceuticals Financial Results

Bafna Pharmaceuticals reported audited financial results for the year ended March 31, 2026. The filing includes the Balance Sheet, Cash Flow, and an unmodified auditor's report.

Source

NSE filing, NSE: BAFNAPH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bafna Pharmaceuticals Ltd: key numbers

Share price
₹451.60
Market cap
₹1,068 Cr
Revenue (annual)
₹150.6 Cr
Net profit (annual)
₹11.10 Cr
P/E (TTM)
137.2×Sector 46.1×
Promoter holding
75.00%+0.00% QoQ
FII holding
9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bafna Pharmaceuticals Ltd

All →

Other financial results announcements

All →